Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Finasteride for hair loss increases risk of sexual dysfunction in young men.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Eucalyptol and oleic acid in nanoemulsions improve minoxidil delivery to hair follicles, potentially enhancing hair loss treatment.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Chitrak is a medicinal plant with health benefits like fighting microbes, reducing inflammation, and promoting hair growth, but it can be toxic and needs more research.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Fluocinolone acetonide slows down hair follicle stem cells but speeds up skin cell growth in mice.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

The model and estimator can predict drug exposure in kidney transplant patients well.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.